Log in to your Inderes Free account to see all free content on this page.
Novo Nordisk
251.85 DKK
+2.32 %
1,012 following
NOVO B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Novo Nordisk
P/E
Median 2019-2025
EV/S
Median 2019-2024
EV/EBIT
Median 2019-2024
Dividend yield
Median 2019-2025
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (DKK) | 193.33 | 213.33 | 367.50 | 469.00 | 698.10 | 624.20 | 325.25 |
| Shares | 4,747.2 | 4,669.0 | 4,594.2 | 4,508.0 | 4,510.0 | 4,446.2 | 4,444.0 |
| Market cap | 917,757.9 | 996,020.8 | 1,688,378.8 | 2,114,252.0 | 3,148,431.0 | 2,775,318.0 | 1,445,411.0 |
| Enterprise value | 908,099.9 | 995,018.8 | 1,698,818.8 | 2,127,383.0 | 3,161,045.0 | 2,862,450.0 | - |
| EV/S | 7.4 | 7.8 | 12.1 | 12.0 | 13.6 | 9.9 | - |
| EV/EBITDA | 15.6 | 16.6 | 26.3 | 25.9 | 28.2 | 19.4 | - |
| EV/EBIT | 17.3 | 18.4 | 29.0 | 28.4 | 30.8 | 22.3 | - |
| P/E | 23.6 | 23.6 | 35.4 | 38.3 | 37.4 | 27.5 | 14.1 |
| P/B | 15.94 | 15.73 | 23.87 | 25.32 | 29.55 | 19.34 | 7.45 |
| P/S | 7.5 | 7.8 | 12.0 | 11.9 | 13.6 | 9.6 | 4.7 |
| Dividend yield | 2.2 % | 2.1 % | 1.4 % | 1.3 % | 1.4 % | 1.8 % | 3.6 % |
| Equity ratio | 45.8 % | 43.7 % | 36.4 % | 34.6 % | 33.9 % | 30.8 % | 35.7 % |
| Gearing ratio | 10.1 % | 18.6 % | 39.5 % | 30.9 % | 25.3 % | 71.6 % | 67.5 % |
Login required
This content is only available for logged in users